BioSpace News Archive

Eli Lilly and Company announced that it will invest an additional $1.6 billion and add another 200 new jobs at its two new manufacturing sites within LEAP Innovation Park in Boone County, bringing the company’s total commitment to $3.7 billion and up to 700 new jobs.

City of Hope, one of the largest cancer research and treatment organizations in the United States and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, announced that Andrew T. Leitner, M.D., has been appointed chair of the Department of Supportive Care Medicine and Arthur M. Coppola Family Chair in Supportive Care Medicine.

Abivax SA today reports the results from the final analysis of its Phase 2b open-label maintenance study, including 164 patients who completed the second year of once-daily oral treatment with 50mg obefazimod.

Vincerx Pharma, Inc. presented a poster of preclinical data on novel integrin αvβ3-targeted small molecule drug conjugates at the American Association for Cancer Research Annual Meeting.

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that Cleveland Clinic presented the most up-to-date data from the Phase 1 Trial of its breast cancer vaccine.

Nurix Therapeutics, Inc. today announced presentations covering its targeted protein degradation programs, including the structural disclosure of NX-2127 and new preclinical data for NX-2127 and NX-5948, highlighting their superior activity against acquired mutations in Bruton’s tyrosine kinase (BTK), a key therapeutic target in the treatment of B-cell malignancies.

MapKure, LLC, SpringWorks Therapeutics, Inc., and BeiGene, Ltd., announced that they will present updated clinical data from the Phase 1a/1b study of BGB-3245, an investigational, selective RAF dimer inhibitor, in adult patients with advanced or refractory solid tumors harboring MAPK pathway aberrations.

Stevanato Group S.p.A. announced that it will issue financial results for the first quarter of 2023 on Thursday, May 4, 2023, at 6:30 a.m.